Clinica's Indian Market Briefing

Product Code CLI00009
Publication Date January 2006
Publisher Clinica
Product Type Report
Pages 87
ISBN Number not applicable
Change currency
PDF £500.00 €602 $791 BUY >
PRINT £500 €602 $791 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Clinica's Indian Market Briefing

India's large and expanding population, rapidly growing economy and much needed structural reforms are having a significant impact on the development of the healthcare market.There is a greater spread of consumer purchasing power as the middleincome group expands, and government support for private enterprise within the healthcare sector is encouraging expansion of service providers and the development of innovative health products to address country specific needs.

Due to the country's low GDP per capita, the mass market is price-sensitive and tends to follow a high volume low margin model. The exception is hightechnology equipment, where in some cases lack of competition allows higher margins. Once in the market, advantage can be gained from

&qot;indigenising&qot; a product and using the base as a launch pad into the rest of Asia. The demand for technology is strong in both the public and private sector.

The private tertiary care sector currently offers an attractive market benefiting from efficient procurement methods and fewer cash-flow constraints. Currently only the top third of income earners can afford to pay for healthcare, but the number of people buying healthcare insurance is growing.

Spending on healthcare is set to increase with a rise in chronic, lifestyle and age-related diseases, which are typically more expensive to treat than infectious diseases. The cardiovascular, asthma and cancer segments are therefore expected to grow in importance.The smallest segment in India's healthcare industry, the in vitro diagnostics (IVD) business, is doing well despite comparatively less government interest in this sector.

A trend towards accreditation is boosting the interest in imported kits and there is a growing interest in automated systems, and a demand for new improved tests and user-friendly products. Strongest demand is in the infectious disease, genetic disorder, cancer and pharmacogenetics segments. Not all IVD segments are growing at the same rate. Molecular diagnostics has strong potential because clinicians perceive a good cost-benefit ratio associated with these products. Companies and private hospitals are tapping the telemedicine, e-health and mobile health markets. These segments are crucial to achieving universal healthcare in a country where 70% of the population live in underdeveloped or inaccessible areas. There is also an increasing demand to provide distant diagnostic services for overburdened hospitals in the US and the UK.

International demand in the form of medical tourism is driving the market for high-end equipment and procedures. This market is growing rapidly and being targeted by both the private sector and state governments, which are tailoring facilities, offerings and organisational bodies to respond to the demand. Companies that are established in the Indian market or planning to enter the market are predominately positive. Once the right partner and a good workforce have been secured, business seems to be brisk and relatively problem free.Concerns about intellectual property protection are not great for makers of high-end equipment because domestic manufacturing capabilities are not sufficiently developed to present a major challenge. However, companies have several IP protection measures. These are supported by the legal system, which is considered to be largely effective.

Bureaucracy and corruption are burdens that hinder medical device market development in the public sector and where professional assistance is strongly advised.

Challenges for smaller international companies include investing time and money to conduct market research, the physical distances between an overseas operational base and the distributors and end consumers in India, understanding the business and social culture, infrastructure inadequacies, and building an attainable business plan.

Contents

  • Chapter 1 Economic Overview
    • 1.1 Introduction
    • 1.2 Domestic Environment
    • 1.3 Economic Outlook
    • 1.4 Other Initiatives
  • Chapter 2 Healthcare System
    • 2.1 Introduction
    • 2.2 Insurance
    • 2.3 Declining Public Sector Spending
    • 2.4 The Rural-Urban Imbalance
      • 2.4.1 An Ideal Scenario
    • 2.5 Accreditation
    • 2.6 Concerns around Diagnostic Service Providers
    • 2.7 Equipment Usage
    • 2.8 The Clinical Establishment Act
    • 2.9 Medical Visas
    • 2.10 Foreign Direct Investment (Fdi)
    • 2.11 Regulation of Medical Devices
    • 2.12 Public-Private Partnerships (PPPs)
    • 2.13 Infrastructure Development
    • 2.14 Demographic and Epidemiological Trends
  • Chapter 3 Doing Business
    • 3.1 Introduction
    • 3.2 The Nature of The Market
    • 3.3 Intellectual Property (IP)
    • 3.4 Bureaucracy
    • 3.5 Entering The Market
      • 3.5.1 Procurement Issues
      • 3.5.2 Special Economic Zones (SEZs)
      • 3.5.3 Business Centres
      • 3.5.4 Public-Private Partnerships (PPPs)
    • 3.6 Import Information
    • 3.7 Culture
    • 3.8 Travel
    • 3.9 Business Challenges
    • 3.10 Key Advice
  • Chapter 4 The Medical Device Market
    • 4.1 Introduction
    • 4.2 Market Size, Growth and Forecasts
    • 4.3 Indian Manufacturing
    • 4.2 Epidemiological Data
      • 4.2.1 Lifestyle and Infectious Diseases
    • 4.3 Regulation
      • 4.3.1 Medical Devices
        • 4.3.1.1 Import
        • 4.3.1.2 Manufacture
        • 4.3.1.3 Sale
        • 4.3.1.4 Industry Reactions and Suggestions
    • 4.4 New Regulatory Areas
      • 4.4.1 Blood Banks, Medical Imaging
      • 4.4.2 Stem Cells
      • 4.4.3 Clinical Trials
      • 4.4.4 Diagnostic Kits and Reagents
  • Chapter 5 Medical Device Sectors
    • 5.1 Hospitals
      • 5.1.1 International Partnerships
      • 5.1.2 Leading Corporate Hospitals
        • 5.1.2.1 Other Key Hospitals
    • 5.2 The Rural Sector
    • 5.2 Telemedicine (Distant Monitoring and Treatment of Patients)
      • 5.2.1 Leading Providers of Telemedicine Services
    • 5.3 Preventive Healthcare and in Vitro Diagnostics
      • 5.3.1 in Vitro Diagnostics
        • 5.3.1.1 Market Characteristics
        • 5.3.1.2 Needs and Trends
        • 5.3.1.3 Methods
        • 5.3.1.4 Market Drivers
      • 5.3.2 Segment Data
        • 5.3.2.1 Biochemistry Equipment and Reagents
        • 5.3.2.2 Haematology Equipment and Reagents
        • 5.3.2.3 Immunoassay Equipment and Reagents
        • 5.3.2.4 Microbiology, Molecular Biology and Others
        • 5.3.2.5 Molecular Diagnostics Market
        • 5.3.2.6 Biochemistry
      • 5.3.3 Challenges Facing India's Ivd Sector
    • 5.4 Medical Tourism
  • Chapter 6 Companies and Opinion Leaders
    • 6.1 Medical Technology Companies in India
      • 6.1.1 Indian Companies
        • 6.1.1.1 Sahajanand Medical Technologies
        • 6.1.1.2 Wipro Biomed
          • Www.Wiprobiomed.in
          • Products
        • 6.1.1.3 Wipro Technologies and Ge Healthcare
        • 6.1.1.4 Blue Star India
        • 6.1.1.5 Trivitron
        • 6.1.1.6 Bpl
        • 6.1.1.7 Angiplast
        • 6.1.1.8 Hindustan Syringes & Medical Devices
        • 6.1.1.9 Rac Exports
        • 6.1.1.10 J Mitra & Co
      • 6.1.2 International Companies
        • 6.1.2.1 Johnson & Johnson
        • 6.1.2.2 Philips Medical Systems India
        • 6.1.2.3 Siemens Medical Solutions Ltd
        • 6.1.2.4 Hitachi India Pvt Ltd
        • 6.1.2.5 Boston Scientific Corporation
        • 6.1.2.6 Roche Diagnostics India Ltd
        • 6.1.2.7 Larsen & Toubro Medical Equipment
        • 6.1.2.8 Becton Dickinson India
        • 6.1.2.9 3M Health Care
        • 6.1.2.10 Ansell
    • 6.2 Diagnostics Companies in India
      • 6.2.1 Indian Diagnostics Companies
        • 6.2.1.1 Span Diagnostics
  • Products
    • 6.2.2 Other Prominent Indian Diagnostics Companies
    • 6.2.3 International Diagnostics Companies in India
  • 6.3 Laboratories
  • 6.4 Leading Industry Figures
    • 6.4.1 Dr Govindappa Venkataswamy
    • 6.4.2 Dr Devi Shetty
    • 6.4.3 Dr Naresh Trehan
    • 6.4.4 Dr Raghunath Mashelkar
    • 6.4.5 Dr Abdul Kalam, President of India
    • 6.4.6 Kapil Sibal, Minister of Science and Technology
  • List of Tables
    • Table 1.1 General Economic Data
    • Table 2.1 Compared Growth of Public & Private Expenditures
    • Table 2.2 Life Expectancy and Healthcare Spending
    • Table 2.3 Rural-Urban Funding Disparities 2002/2003 (Rs Million, per Capita)
    • Table 2.4 Estimate of Required Providers and Facilities
    • Table 2.5 A Selected Epidemiological Profile
    • Table 2.6 Population Distribution According to Age
    • Table 3.1 History of The Special Economic Zones
    • Table 3.2 Cultural Catchwords, Notes and Advice
    • Table 4.1 Medical Equipment Imports and Exports
    • Table 4.2 Selected Exports to India: Volume (Top Line Figs)/Value (Lower Line Figs) (Rupees Million) 1991-2003
    • Table 4.3 Projected Deaths by Cause, All Ages, India 2005
    • Table 4.4 Infectious Diseases Profile
    • Table 4.5 Diagnostics Value and Growth Statistics
    • Table 4.6 Selected Information about Other Prevalent Health Conditions:
    • Table 5.1 Healthcare Infrastructure